9:22 AM
Leo Group India
| ||
| ||
| Bristol-Myers to buy Amylin Pharmaceuticals gulfnews.com New York: Bristol-Myers Squibb Co agreed to pay $5.3 billion (Dh19.46 billion) to acquire Amylin Pharmaceuticals Inc, a maker of diabetes therapies, as it seeks to replace revenue from its top-selling blood thinner that's facing generic competition. See all stories on this topic » | ||
| AstraZeneca hungry to refill medicine cabinet Reuters India Faced with one of the steepest "patent cliffs" in the pharmaceutical industry, which will savage sales of its current top-selling medicines over the next five years, AstraZeneca has been under mounting pressure to do something to shore up its business ... See all stories on this topic » | ||
| Domestic pharmaceutical firm plans NT$1.1 billion investment Focus Taiwan News Channel Taipei, June 30 (CNA) ScinoPharm Taiwan Ltd., one of the leading biotechnology companies in the country, said Friday it plans to invest NT$1.1 billion (US$37.6 million) in a project to manufacture high-potency injectable drugs for cancer treatment. See all stories on this topic » | ||
| Pfizer takes Alembic to US court on drug patent Business Standard Vadodara-based Alembic and US-based Breckenridge Pharmaceutical have been named co-defendants in a suit filed by Pfizer in response to their separate Abbreviated New Drug Application (ANDA) to market desvenlafaxine succinate extended-release ... See all stories on this topic » | ||
| ||
| Sucampo Pharmaceuticals Provides Update on Anticipated Arbitration Decision MarketWatch (press release) Sucampo Pharmaceuticals, Inc., an international pharmaceutical company is focused on the discovery, development and commercialization of proprietary drugs based on prostones. The therapeutic potential of prostones, which occur naturally in the human ... See all stories on this topic » | ||
| Bristol-Myers Squibb and AstraZeneca Expand Diabetes Alliance Through ... MarketWatch (press release) Bristol-Myers Squibb Company (NYSE:BMY) and Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) announced today that Bristol-Myers Squibb will acquire Amylin for $31.00 per share in cash, pursuant to a cash tender offer and second step merger, or an ... See all stories on this topic » | ||
| CORRECTING and REPLACING Sucampo Pharmaceuticals Provides Update ... MarketWatch (press release) Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) today announced that the International Court of Arbitration, International Chamber of Commerce (ICC) has notified the Company of a change in the anticipated date of the decision related to the Company's ... See all stories on this topic » | ||
| Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year ... MarketWatch (press release) NORTHVALE, N.J., Jun 29, 2012 (GlobeNewswire via COMTEX) -- Elite Pharmaceuticals, Inc. (OBB:ELTP) , a specialty pharmaceutical company dedicated to developing and commercializing oral controlled release product formulations and the manufacturing ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment